From d4b1d0ade482c3581d0b7d2c628a8a5186739bcb Mon Sep 17 00:00:00 2001
From: Isabell Guckes <isabell.guckes@uni-bielefeld.de>
Date: Sun, 29 Sep 2024 10:42:41 +0200
Subject: [PATCH] text changes
---
src/contents/description.tsx | 2 +-
1 file changed, 1 insertion(+), 1 deletion(-)
diff --git a/src/contents/description.tsx b/src/contents/description.tsx
index 267e1b1c..ce7d4a7b 100644
--- a/src/contents/description.tsx
+++ b/src/contents/description.tsx
@@ -184,7 +184,7 @@ export function Description() {
<img src="https://static.igem.wiki/teams/5247/delivery/sort-lnp-ohne-beschriftung.webp"/>
</div>
<div className='col'>
- <p>We optimized lipid nanoparticles (LNPs) as a robust delivery system to transport larger therapeutic cargo, such as Prime Editing mRNA, to lung epithelial cells via inhalation. LNPs were chosen over other delivery systems, like Adeno-associated viruses (AAVs), due to their superior cargo capacity and reduced immunogenicity. Our goal is to create a lung-specific LNP, named AirBuddy, capable of efficiently delivering of our Prime Editing components, referred to as PrimeGuide, to lung tissues through inhalation. This approach is designed to advance precision medicine by ensuring targeted delivery with minimal off-target effects.</p>
+ <p>We optimized lipid nanoparticles (LNPs) as a robust delivery system to transport larger therapeutic cargo, such as Prime Editing mRNA, to lung epithelial cells via inhalation. LNPs were chosen over other delivery systems, like Adeno-associated viruses (AAVs), due to their superior cargo capacity and reduced immunogenicity. Our goal was to create a spray-dried lung-specific LNP named AirBuddy, capable of efficiently delivering of our Prime Editing components, referred to as PrimeGuide, to lung tissues through inhalation. This approach is designed to advance precision medicine by ensuring targeted delivery with minimal off-target effects.</p>
</div>
</div>
<Collapsible id="Col1" open={false} title="LNPs explained">
--
GitLab